2017 Small-Cap Biotech Watchlist Update: Up 21% at the End of Q2/17

Source: Streetwise Reports   07/13/2017 If an investor had purchased an equal dollar amount of each company on The Life Sciences Report’s 2017 Small-Cap Biotech Watchlist at the beginning of the year, . . . → Read More: 2017 Small-Cap Biotech Watchlist Update: Up 21% at the End of Q2/17 Similar Articles: RXi Pharmaceuticals Expands Collaboration with Norwegian Cancer Firm; Gears Up for 2017 Milestones 2017 Small-Cap Biotech Watchlist Update: Holding Steady in a Volatile Market 2017 Small-Cap Biotech Watchlist: Takeaways for Investors